Vertex Pharmaceuticals Incorporated

Vertex has big plans to replicate its huge success in cystic fibrosis with new therapies in pain and cell therapy, but is coming up against some major obstacles. Its investigational pain therapy, VX-9

Upcoming federal spending reductions and resulting coverage losses in Medicaid could have a significant impact on patient access to drugs for HIV, cystic fibrosis and mental health, as well as treatme

While cuts to Medicaid under the recent budget bill have been grabbing the most headlines, the Centers for Medicare and Medicaid Services is also heralding progress in implementing a Medicaid program

Thirty-three states plus the District of Columbia and Puerto Rico committed to adopting standardized utilization management policies for at least one of the gene therapies for sickle cell disease on t